论文部分内容阅读
目的分析单唾液酸神经节苷脂注射液治疗新生儿缺氧缺血性脑病的临床治疗效果。方法回顾分析74例新生儿缺氧缺血性脑病患儿的临床资料。结果两组患者实施治疗后,在治疗后第2、7、10天对患者进行随访,结果显示,治疗组患者治疗总有效率为93.5%,对照组治疗总有效率为79.1%,两组患者治疗总有效率对比,治疗组患者显著优于对照组对比差异有统计学意义(P<0.05)。结论采用单唾液酸神经节苷脂注射液治疗新生儿缺氧缺血性脑病,疗效显著,可对因缺血缺氧所导致的脑水肿病症起到较好的抑制作用,有利于脑神经细胞损伤后快速修复,值得临床应用。
Objective To analyze the clinical effect of monosialoganglioside injection on neonatal hypoxic-ischemic encephalopathy. Methods The clinical data of 74 neonates with hypoxic-ischemic encephalopathy were retrospectively analyzed. Results After the two groups of patients were treated, the patients were followed up on the 2nd, 7th and 10th days after treatment. The results showed that the total effective rate was 93.5% in the treatment group and 79.1% in the control group. Both groups The total effective rate of treatment, the treatment group was significantly better than the control group, the difference was statistically significant (P <0.05). Conclusion The treatment of neonatal hypoxic-ischemic encephalopathy with monosialoganglioside injection has significant curative effect, which can inhibit cerebral edema caused by hypoxia and hypoxia, and is beneficial to cerebral neurons Rapid repair after injury, it is worth clinical application.